5mg Mounjaro Not Working? Here's What the Evidence Says

Step 1, Understand where 5mg sits in the treatment sequence

Mounjaro's dose schedule exists for a reason. Treatment begins at 2.5mg for the first four weeks, not because 2.5mg is expected to produce significant weight loss, but because starting low lets your body adjust to a new medicine and keeps side effects manageable. The 5mg dose, which follows, is still early in that adjustment process.

The licensed UK strengths run from 2.5mg through 5, 7.5, 10, 12.5, and 15mg. According to the NHS's tirzepatide patient information, titration typically happens in four-week steps guided by your prescriber. Most of the headline trial results (the ~20–21% average body-weight reduction reported in SURMOUNT-1) came at 15mg after 72 weeks. At 5mg, you are a matter of weeks into a course designed to span many months. That context matters.

Many people on Mounjaro describe 5mg as the point where they first notice something, but not the point where everything clicks. That often changes at 7.5mg and above. Patience at this stage is genuinely part of the clinical plan, not a consolation.

Step 2, Rule out the common reasons results feel absent

Before concluding the dose isn't working, it's worth going through the most frequent reasons people don't see the response they expected at 5mg.

Storage. Tirzepatide must be kept refrigerated at 2–8°C. A pen left on the bathroom shelf, in a warm car, or taken out of the fridge for too long loses potency. If yours lives in the fridge door next to the butter, that's fine, what matters is it stays consistently cold between uses. The Mounjaro SmPC on the eMC gives the exact room-temperature window; always check it rather than estimating.

Injection technique. Subcutaneous injections need to reach the fatty tissue beneath the skin. If the pen is pressed too lightly or the site isn't rotated regularly, delivery can be inconsistent. Abdomen, thigh, and upper arm are all licensed sites; rotating between them each week helps.

Dietary pattern. Mounjaro reduces appetite, but it doesn't override a sustained caloric surplus. Some people unconsciously compensate for reduced hunger at one meal by eating more at another, keeping a rough food diary for a week can be revealing.

If storage and technique check out and the dietary picture is reasonable, the most likely explanation is simply that 5mg is below your individual therapeutic threshold, and our page on what to do when Mounjaro isn't working is a practical place to start before speaking to your prescriber. Our page on why Mounjaro sometimes stalls weight loss covers the broader picture in more depth.

Step 3, Know when to contact your prescriber, and what they'll consider

You should complete a full four weeks at 5mg before drawing conclusions about its effectiveness. One or two weeks isn't enough, tirzepatide's steady-state plasma concentration takes time to establish, and weight loss rarely moves in a straight line even when the medicine is working.

After four weeks with no meaningful change in appetite or weight, the right move is to speak to your prescriber rather than stopping or adjusting the dose yourself. They'll look at your starting weight, any weight lost so far, side-effect profile, and whether there are reasons to stay at 5mg a little longer or to titrate upward. At nume, a GPhC-registered prescriber reads your progress notes personally, a real clinician, not a decision tree.

There are also legitimate medical reasons a prescriber might hold a dose: ongoing nausea that hasn't settled, certain comorbidities, or recent changes to other medicines. If you're finding that Mounjaro isn't working for you, our page addresses interactions and medical factors in detail.

On the question of cost when dose changes are involved, it helps to understand the full picture of what Mounjaro costs privately in the UK, including how pricing shifts by dose.

Step 4, What the evidence says about higher doses and longer timelines

The SURMOUNT-1 trial, published in the New England Journal of Medicine, randomised thousands of adults with obesity to tirzepatide or placebo over 72 weeks. Weight loss at the 10mg and 15mg doses substantially outpaced what participants experienced at lower doses and earlier time points. This isn't incidental, it reflects how a dual GIP and GLP-1 receptor agonist builds its effect progressively as the dose increases.

NICE's appraisal of tirzepatide (TA1026) recommends that if less than 5% weight loss has occurred after six months at the highest tolerated dose, continuing treatment should be reviewed. The key phrase there is highest tolerated dose, 5mg is not that, for most people. The clinical expectation is that response improves as titration continues, within the limits of tolerability.

If you've read about how long Mounjaro takes to work and you're still within the early months of treatment, the most evidence-based thing you can do is stay the course under clinical supervision, titrate as advised, and report back honestly at each review. The full story of whether Mounjaro is right for you can't be told at 5mg.